within Pharmacolibrary.Drugs.ATC.D;

model D08AH03
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.6,
    Cl             = 1.9999999999999998e-05,
    adminDuration  = 600,
    adminMass      = 250 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.04,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0008333333333333334,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>D08AH03</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Oxyquinoline (8-hydroxyquinoline) is an antimicrobial agent and chelating compound previously utilized in topical preparations and as a disinfectant. It was used for the treatment of skin infections and as an antiseptic, but is not widely used or approved as a pharmaceutical agent in modern medicine.</p><h4>Pharmacokinetics</h4><p>No published human pharmacokinetic data available; values are estimated based on physicochemical properties and analogy to related hydroxyquinoline compounds in healthy adults.</p><h4>References</h4><ol><li><p>Mao, X, &amp; Schimmer, AD (2008). The toxicology of Clioquinol. <i>Toxicology letters</i> 182(1-3) 1–6. DOI:<a href=\"https://doi.org/10.1016/j.toxlet.2008.08.015\">10.1016/j.toxlet.2008.08.015</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/18812216/\">https://pubmed.ncbi.nlm.nih.gov/18812216</a></p></li><li><p>Bareggi, SR, &amp; Cornelli, U (2012). Clioquinol: review of its mechanisms of action and clinical uses in neurodegenerative disorders. <i>CNS neuroscience &amp; therapeutics</i> 18(1) 41–46. DOI:<a href=\"https://doi.org/10.1111/j.1755-5949.2010.00231.x\">10.1111/j.1755-5949.2010.00231.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/21199452/\">https://pubmed.ncbi.nlm.nih.gov/21199452</a></p></li><li><p>Bondiolotti, G, et al., &amp; Bareggi, SR (2007). Pharmacokinetics and distribution of clioquinol in golden hamsters. <i>The Journal of pharmacy and pharmacology</i> 59(3) 387–393. DOI:<a href=\"https://doi.org/10.1211/jpp.59.3.0008\">10.1211/jpp.59.3.0008</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/17331342/\">https://pubmed.ncbi.nlm.nih.gov/17331342</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end D08AH03;
